Allworth Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Allworth Financial’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$549	Hold	5	–	–	﹤0.01%	4715
2025 Q4	$546	Hold	5	–	–	﹤0.01%	4510
2025 Q3	$478	Sell	5 -380	-99%	-$33.3K	﹤0.01%	4444
2025 Q2	$33.9K	Buy	385 +36	+10%	+$3.12K	﹤0.01%	2182
2025 Q1	$30.1K	Hold	349	–	–	﹤0.01%	1827
2024 Q4	$30K	Hold	349	–	–	﹤0.01%	1846
2024 Q3	$33.2K	Hold	349	–	–	﹤0.01%	1595
2024 Q2	$32.1K	Hold	349	–	–	﹤0.01%	1586
2024 Q1	$31.7K	Hold	349	–	–	﹤0.01%	1510
2023 Q4	$28.4K	Buy	+349	New	+$27.4K	﹤0.01%	1443
2023 Q3	–	Sell	-74	Closed	-$5.83K	–	3524
2023 Q2	$5.83K	Buy	+74	New	+$5.79K	﹤0.01%	2041

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Allworth Financial's PPH Position: Q1 2026 in Review

Allworth Financial held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 5 shares worth $549. The position accounts for ﹤0.01% of the portfolio, ranked #4715.

Allworth Financial first reported a position in PPH in Q2 2023 and has held it in 11 quarters since. The position peaked at $33.9K in Q2 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Allworth Financial held 5 shares of VanEck Pharmaceutical ETF worth $549 as of Q1 2026.
Allworth Financial left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4715 holding.
Allworth Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and has held it in 11 quarters since.
Allworth Financial's VanEck Pharmaceutical ETF position peaked at $33.9K in Q2 2025.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.